-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
medsci.
medsci.
Tumor necrosis factor alpha antagonist (anti-TNF) is one of the most effective drugs to induce and maintain moderate to severe UC remission.
The researchers collected clinical data on anti-TNF therapy in UC patients.
infection
The study cohort included a total of 2257 patients (including 231 patients 60 years of age or older).
Figure: The therapeutic effect of anti-TNF preparations on ulcerative colitis
This study confirmed that elderly UC patients received anti-tumor necrosis factor therapy increased the risk of SAE, but there was no difference in the efficacy of anti-TNF therapy between elderly and young patients.
This study confirmed that elderly UC patients received anti-tumor necrosis factor therapy increased the risk of SAE, but there was no difference in the efficacy of anti-TNF therapy between elderly and young patients.
Original source:
David Cheng.
Safety and Efficacy of Tumor Necrosis Factor Antagonists in Older Patients With Ulcerative Colitis: Patient-Level Pooled Analysis of Data From Randomized Trials.
Leave a message here